HEMOSTASIS AND THROMBOSIS RESEARCH SOCIETY INC (EIN 391796672) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

1994

Legal Domicile

Principal Officer

LORILYN JACOBSEN-TEWS

Phone

4149376569

Tax Period

2023-01-01 to 2023-12-31

HEMOSTASIS AND THROMBOSIS RESEARCH SOCIETY INC, founded in 1994, is a community nonprofit in the Unknown sector that reported $2.7M in total revenue in fiscal year 2023. Revenue surged 51% from the prior year, signaling strong growth momentum. Expenses of $2.5M left a modest 4% surplus.

Mission

TO BE THE LEADING NONPROFIT PROFESSIONAL SOCIETY IN NORTH AMERICA DEDICATED TO RESEARCH, MENTORING, WORKFORCE DEVELOPMENT, AND CONTINUING MEDICAL EDUCATION FOR PHYSICIANS, INVESTIGATORS, AND ALLIED HEALTH PROFESSIONALS INTERESTED IN ADVANCING CARE FOR PEOPLE WITH HEMOSTATIC AND THROMBOTIC DISORDERS.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $2,010,156

Program Service Revenue $571,170

Investment Income $85,940

Other Revenue $1,351

TOTAL REVENUE $2,668,617

Expense Breakdown

Grants Paid $979,549

Salaries & Benefits $272,888

Fundraising Expenses $1,046

Program Expenses $2,095,035

Other Expenses $1,297,238

TOTAL EXPENSES $2,549,675

Year-over-Year Comparison

	2023	2022	Change
Revenue	$2,668,617	$1,771,378	+0.5%
Expenses	$2,549,675	$1,814,608	+0.4%
Net Income	$118,942	$-43,230	-3.8%

Key Indicators

✓ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$146,690

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
SHANNON CARPENTER MD MS	IMMEDIATE PAST PRESIDENT	3.00	Officer Director	$0	$0	$0
SHANNON MEEKS MD MBA	PRESIDENT	3.00	Officer Director	$0	$0	$0
JORDAN SHAVIT MD PHD	VICE PRESIDENT/PRESIDENT ELECT	3.00	Officer Director	$0	$0	$0
LYNN MALEC MD MSC	TREASURER	3.00	Officer Director	$0	$0	$0
ARASH MAHAJERIN MD MSCR	EDUCATION OFFICER	3.00	Officer Director	$0	$0	$0
BRYCE KERLIN MD	RESEARCH & AWARDS OFFICER	3.00	Officer Director	$0	$0	$0
WOLFGANG BERGMEIER PHD	DIRECTOR (THRU JUNE)	1.50	Director	$0	$0	$0
DEBORAH SIEGAL MD MSC FRCPC	DIRECTOR (THRU JUNE)	1.50	Director	$0	$0	$0
BRIAN BRANCHFORD MD	DIRECTOR (THRU JUNE)	1.50	Director	$0	$0	$0
MARY CUSHMAN MD MSC	DIRECTOR	1.50	Director	$0	$0	$0
ALAN MAST MD PHD	DIRECTOR	1.50	Director	$0	$0	$0
ALISA WOLBERG PHD	DIRECTOR (THRU JUNE)	1.50	Director	$0	$0	$0
MING LIM MBBCHIR MSCR	DIRECTOR	1.50	Director	$0	$0	$0
AYESHA ZIA MD MSCR	DIRECTOR	1.50	Director	$0	$0	$0
GOWTHAMI AREPALLY MD	DIRECTOR (THRU JUNE)	1.50	Director	$0	$0	$0
LORILYN JACOBSEN-TEWS	EXECUTIVE DIRECTOR	40.00	Officer	$119,750	$26,940	$146,690

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$2,668,617	$2,549,675	$4,113,604	$118,942
2022	$1,771,378	$1,814,608	$4,139,914	$-43,230
2021	$1,582,781	$1,761,702	$4,175,317	$-178,921
2020	$1,534,178	$2,101,091	$4,199,965	$-566,913
2019	$4,527,152	$1,873,791	$4,781,435	$2,653,361
2018	$1,831,865	$1,830,545	$3,051,166	$1,320

HEMOSTASIS AND THROMBOSIS RESEARCH SOCIETY INC